Placental villous maturation is maximal in the 3rd trimester, with an abundance of terminal villi. Delayed villous maturation (DVM) of the placenta is associated with chromosomal abnormalities, gestational diabetes, and an adverse outcome. This study compares quantitative assessment of vasculo-syncytial membranes (VSM) in cases of liveborn infants, perinatal deaths, and controls. Cases were selected as follows: (1) liveborn infants with a qualitative diagnosis of DVM (n 5 15); (2) controls matched for gestational age whose placentas did not have DVM (n 5 15); (3) stillbirths (SB)/neonatal deaths (NND) showing DVM (n 5 13); and (4) SB from autopsies in which DVM was felt to be the cause of death (COD) (n 5 12). Vasculo-syncytial membranes were counted in 10 terminal villi in each of 10 consecutive high-power fields on 3 slides. Data analysis was carried out using SPSS. Liveborn cases with DVM showed statistically significantly less VSM than controls (mean 1.01 vs 2.42, P , 0.0001). The SB/NND group also showed significantly less VSM than the control group (mean 0.46 vs 2.42, P , 0.0001) and less than the liveborn DVM group (mean 0.46 vs 1.01, P 5 0.001). The COD group was significantly different from the control group (mean 0.42 vs 2.42, P , 0.0001) and the liveborn DVM group (mean 0.42 vs 1.01, P , 0.0001) but not significantly different from the SB/NND group. There is a quantitative reduction in VSM in cases of DVM compared to controls.
INTRODUCTION
Placental villous maturation is maximal in the 3rd trimester, with an abundance of terminal villi, defined by small-caliber (40-100 mm), minimal stroma and abundant vasculo-syncytial membrane (VSM) formation [1] . Vasculo-syncytial membranes are composed of fetal capillary walls located near the trophoblast basement membrane and a thin layer of trophoblast cytoplasm and facilitate optimal gas exchange ( Fig. 1) . At term, terminal villi account for 40%-50% of placental volume and 60% of the cross-sectional area [2] .
Delayed villous maturation (DVM) is an entity whereby the maturation of the terminal placental villi does not occur normally or takes place to a lesser degree than is normal for gestation. On low-power magnification, the villi are enlarged with increased stromal cellularity and extracellular matrix. On higher-power magnification, many capillaries are not peripherally located, resulting in a decrease in VSM. The villous trophoblast surrounding the villous appears thickened and hypercellular (Fig. 2 ). There are relatively few references to DVM in the literature. It is a placental cause of fetal death [3] and is associated with chromosomal abnormalities [4] and diabetes mellitus [5, 6] .
A risk of recurrence is also documented [7] . In a retrospective study, we showed an association between DVM as defined qualitatively and an adverse perinatal outcome [8] . We have also shown that DVM is not associated with antenatal ultrasound parameters [6] . The literature supports both qualitative and quantitative approaches to the diagnosis of DVM. The aim of this study was to perform a quantitative assessment of VSM in DVM in cases of perinatal deaths and controls.
METHODS
This is a prospective nested cohort study. The study was approved by the hospital's Ethics Committee. Liveborn *Corresponding author, e-mail: anntreacy@mac.com Controls were the next delivery on the database matched individually based on gestational age (n 5 15). Another group was identified from the study cohort of stillbirths (SB) and neonatal deaths (NND) showing DVM on placental histology (n 5 13). Another group was identified, for which DVM was felt to be the cause of death (COD) (n 5 12), from the hospital perinatal autopsy database. The diagnosis of DVM as COD accounted for approximately 3% of autopsy cases .500 g over this period and was made in cases .35 weeks in whom no other cause was found at full autopsy examination. All cases were .35 weeks gestational age. Gross pathologic details of placental examination, including cord pathologies (long cord .85 cm, short ,40 cm, abnormal insertions (marginal, velamentous) and thin cord ,0.8 cm diameter), were noted. Clinical details were obtained from the autopsy report. The evaluation of mothers after SB or NDD included assessment of glycosylated haemoglobin, the result of which was included in the autopsy report.
The mid-portion of placental parenchyma was assessed in 3 sections from each placenta. Ten consecutive high-power fields were evaluated and VSM counted in each of 10 terminal villi in each field. A VSM was that part of the villus in which the fetal vessel lumens and the intervillous space were separated by only a thin layer composed of villous trophoblast cytoplasm, endothelial cytoplasm, and their respective basement membranes [7] .
Data were analyzed using SPSS version 17.0 (SPSS, Chicago, IL, USA). The data were not distributed normally, and therefore the nonparametric Mann-Whitney U-test was used for comparison of group means. Statistical significance was set at P 5 0.05.
RESULTS
Liveborn cases with DVM showed statistically significantly less VSM than controls (mean 1.01 vs 2.42, P ,0.0001).
The SB/NND group also showed significantly less VSM than control group (mean 0.46 vs 2.42, P , 0.0001) and less than the liveborn DVM group (mean 0.46 vs 1.01, P 5 0.001).
The COD group was significantly different from the control group (mean 0.42 vs 2.42, P , 0.0001) and from the liveborn DVM group (mean 0.42 vs 1.01, P , 0.0001) but not significantly different from the SB/NND group.
Diabetes mellitus was documented in 2 of the DVM case group and 3 of the control group. No diabetic cases were identified in the SB/NND or COD groups.
No chromosomal abnormalities were documented in the DVM liveborn group.
The SB/NND group showed 1 trisomy 21 (Down syndrome) and 3 trisomy 18 (Edward syndrome) cases, and the COD group had 1 infant with trisomy 21. Ten (77%) of the SB/NND group had autopsies performed. Autopsy revealed that placental analysis congenital abnormalities were the cause of death in 6 cases, 2 of fetomaternal hemorrhage. There were 2 unexplained (1 dichorionic twin) and 1 each of nonimmune hydrops, fetal thrombotic vasculopathy, and cord accident. Sixteen of the 20 cases (80%) that underwent autopsy examination showed maceration. Nine cases showed severe maceration, 6 cases showed moderate, and 1 case showed mild.
DISCUSSION
This study has shown that there is a spectrum of severity of DVM present in at-risk clinical groups, with the groups of NND and SB showing the fewest VSM. The placentae from cases of SB from both the SB/NND and COD groups had significantly lower numbers of VSM when compared with placentae from liveborn infants showing DVM. This supports the opinions in the literature regarding the clinical relevance of DVM. Stallmach reported a 5.7% incidence of DVM in 15 415 cases, with 2.3% of cases DVM associated with SB [7] . We have confirmed this association, reporting an incidence of 8.6% of intrauterine death and 3.7% of NND [8] .
Although DVM accounts for a relatively small percentage of total perinatal loss (4%) [9] , it may recur. The potential for recurrence is reported at 5.4% [7] , a finding supported by the current study, in which 2 patients (5%) had recurrent DVM. Detailed placental examination is an integral part of the investigation of SB and NND [3, 9, 10] , and the diagnosis of DVM should be actively considered in cases of apparent unexplained SB. The effects of DVM are not confined to SB or NND and may play a role in other adverse outcomes; marked distal villous immaturity was reported in 2 of 158 cases of placentas from term infants with cerebral palsy [11] .
As with many placental pathologies, the diagnosis of DVM may be approached in a qualitative or a quantitative fashion. Stallmach's method of assessing 10 terminal villi in 10 high-power fields in 3 sections of parenchyma was the method used in this study [7] . Other authors have adopted a qualitative approach using mild, moderate, and severe DVM [5] or a mean number of VSM ,10th percentile [12] . The incidence of DVM reported in the literature is variable, ranging from 5.7% to 7.7% [3, 7] . With a qualitative approach, we reported DVM in approximately 7% of placentas analyzed in our institution [8] . In the current study, qualitative assessment within this cohort, recorded as mild, moderate, or severe, correlated poorly with quantitative mean values (Fig. 3) . Although a linear relationship might have been anticipated, assessment of villous maturity by experienced pathologists shows interobserver variation [10] . Different grades of DVM were present in every clinical group in the current study. However, cases diagnosed as DVM on a quantitative basis all had a mean VSM count ,1.69. We interpret these findings as highlighting the importance of any grade of DVM found on placental examination.
Despite a trend to lower VSM means between liveborn DVM, SB/NND, and COD groups, there was no statistically significant difference. It may be that a decision to attribute the death to DVM only in the absence of another cause disguises its role in a perinatal loss. Delayed villous maturation is a likely mechanism of death in serious congenital anomalies, such as trisomy 18 . Each year, we see DVM in some otherwise normal infants who unexpectedly require aggressive resuscitation at birth and who, we feel, represent ''near-miss'' SB. With increased recognition of DVM in larger cohorts and with a focus on separate assessment of the mechanism of death from the overall diagnosis [13] , any difference between these 2 groups may become clearer.
Delayed villous maturation is associated with diabetes mellitus, with rates of DVM in diabetic placentas ranging from 81% [5] to 16.6% [8] . Hyperglycemia and hyperinsulinaemia of diabetic pregnancies may be one of several mechanisms by which DVM occurs, but in a previous study we did not identify a difference between glycoslated hemoglobin or fructosamine values in pregestational diabetic patients with or without DVM [6] . Two of our liveborn DVM group (13%) and 4 of our control group (26%) had a diagnosis of diabetes mellitus (either gestational or prepregnancy). However, not all placentas from diabetic pregnancies will have DVM, and controls were not selected to exclude diabetic patients. Diabetes is not a homogenous disease [14] .
Chromosomal abnormalities, in particular trisomy 13, 18, and 21, are associated with DVM [4] . There is an increased perinatal loss with trisomy, and DVM may be a mechanism by which this occurs. Rates of DVM in trisomic placentas are reported at 60% [4] , with 2 villous patterns noted histologically and villi with few vessels and the other pattern showing focal hypervascular areas containing abnormal vessels [4, 15] . Although our study included 3 cases of trisomy 18 and 2 of trisomy 21, we did not note the 2 villous patterns.
Hypercoiling of the umbilical cord is also associated with DVM [12] . Hypercoiling is associated with a range of adverse fetal outcomes [16] , but methods of assessment of the coiling index vary [17] . Because of the time scale over which this study took place, coiling was not uniformly recorded. Other cord pathologies were evenly distributed across all groups (data not shown).
Maceration is often viewed as a major problem in histologic assessment, but its presence does not preclude the diagnosis of DVM. Nine of 16 cases (56%) in the current study showed severe maceration. We noted frequent separation of trophoblast from the villous stroma in these cases, and quantitative assessment was more time consuming but not impossible to conduct. We found that quantitation as described above took approximately 20 minutes per case to perform. The extent of maceration did not correlate with either the qualitative grade of DVM or the mean VSM scores (data not shown). Two cases of neonatal death showed moderate and severe DVM, refuting the suggestion that severe DVM is purely an epiphenomenon of maceration.
Various etiologies for the pathogenesis of DVM have been suggested, including increased levels of placental growth factors as seen in diabetes and maternal obesity, vascular changes secondary to hypercoiling of the umbilical cord, and chromosomal abnormalities [18] . Many of these mechanisms have been drawn from clinical and pathologic correlation and are reflected in the results from our study, with DVM occurring in diabetics and in the setting of chromosomal abnormalities.
The terminology used in describing the findings of DVM varies, with ''placental maturation defect'' [7] and more recently ''distal villous immaturity'' [18] being used. Our use of the term ''delayed'' arose from a desire to assist clinicians in making a conceptual separation between this abnormality of maturation and the more familiar pathology reflected by the term ''accelerated maturation.'' In the context of the terms ''accelerated'' and ''delayed,'' we agree with Redline's recent observation that ''affected placentas are really poor phenocopies of normal premature and term placentas'' [18] .
In conclusion, VSM are reduced in cases of DVM compared to controls and may be implicated in the etiology of perinatal mortality. Delayed villous maturation is a placental abnormality that may be present to varying degrees of severity. With an estimated recurrence risk on the order of 5%, an increased awareness of this entity will contribute to the understanding of perinatal mortality.
